Immune Checkpoint Inhibitor Outcomes in NSCLC Across Populations and Practice Settings

Authors:

Abstract
No abstract available
Funding Information
  • University of Texas Southwestern Medical Center
  • Cancer Prevention and Research Institute of Texas (RP220542)

This publication has 29 references indexed in Scilit: